T. Yamori

发表

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

Takashi Tsuruo, Jiro Fujimoto, T. Tsuruo, 1999, Oncogene.

Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group.

T. Yamori, S. Uesato, Manabu Kitagawa, 2002, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors.

Minoru Yoshida, T. Yamori, A. Ito, 2016, European journal of medicinal chemistry.

β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases

M. Shibuya, Ying Xu, Y. Uehara, 2002, Japanese journal of cancer research : Gann.

Isolation of a Novel Gene Showing Reduced Expression in Metastatic Colorectal Carcinoma Cell Lines and Carcinomas

Yusuke Nakamura, Kouichi Ozaki, Takashi Tsuruo, 1997, Japanese journal of cancer research : Gann.

Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1)

K. Miyazono, K. Miyazawa, T. Imamura, 2004, Oncogene.

Total synthesis and biological assessment of (-)-exiguolide and analogues.

H. Kubo, T. Yamori, H. Fuwa, 2011, Chemistry.

Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells.

T. Tsuruo, T. Yamori, H. Makuuchi, 2007, Biological & pharmaceutical bulletin.

Biselyngbyasides, cytotoxic marine macrolides, are novel and potent inhibitors of the Ca2+ pumps with a unique mode of binding

C. Toyoshima, T. Yamori, H. Ogawa, 2015, FEBS letters.

Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling.

T. Yamamoto, T. Yamori, Y. Yamanashi, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Cleavage mechanism and anti-tumor activity of 3,6-epidioxy-1,10-bisaboladiene isolated from edible wild plants.

M. Kawada, T. Yamori, N. Aburai, 2012, Bioorganic & medicinal chemistry.

A human IAP-family gene, apollon, expressed in human brain cancer cells.

T. Tsuruo, M. Naito, T. Mashima, 1999, Biochemical and biophysical research communications.

Proteomic analysis of phosphoproteins sensitive to a phosphatidylinositol 3-kinase inhibitor, ZSTK474, by using SELDI-TOF MS

T. Yamori, T. Akashi, Tetsuyuki Akashi, 2009, Proteome Science.

Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26.

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1983, Cancer research.

Identification of Chrysoplenetin from Vitex negundo as a Potential Cytotoxic Agent against PANC‐1 and a Panel of 39 Human Cancer Cell Lines (JFCR‐39)

A. Tomida, H. Esumi, T. Yamori, 2011, Phytotherapy research : PTR.

Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma

H. Saji, K. Matsushima, M. Koike, 2001, Cancer.

Low metastatic potential of clone from murine colon adenocarcinoma 26 increased by transfection of activated c-erbB-2 gene.

T. Tsuruo, T. Yamamoto, Y. Sugimoto, 1990, Journal of the National Cancer Institute.

Total synthesis of the bicyclic depsipeptide HDAC inhibitors spiruchostatins A and B, 5''-epi-spiruchostatin B, FK228 (FR901228) and preliminary evaluation of their biological activity.

Minoru Yoshida, T. Yamori, H. Abe, 2009, Chemistry.

Possible Contribution of Drug Approval Summaries Published by Drug Regulatory Authorities on Scientific Discussion and Drug Development

T. Yamori, K. Tanese, 2020, Clinical pharmacology in drug development.

Advances in development of phosphatidylinositol 3-kinase inhibitors.

Dexin Kong, T. Yamori, 2009, Current medicinal chemistry.

Variation in cytostatic constituents of a sponge-derived Gymnascella dankaliensis by manipulating the carbon source.

Makoto Tanaka, T. Yamori, A. Numata, 2007, Journal of natural products.

Novel tamoxifen derivative Ridaifen-B induces Bcl-2 independent autophagy without estrogen receptor involvement.

M. Ikekita, S. Dan, Y. Nagahara, 2013, Biochemical and biophysical research communications.

The Direct Effect of IL-12 on Tumor Cells: IL-12 Acts Directly on Tumor Cells to Activate NF-κB and Enhance IFN-γ-Mediated STAT1 Phosphorylation

H. Fujiwara, Toshinori Ito, H. Matsuda, 2001 .

Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats

Y. Takasaki, T. Yamori, N. Tamura, 2012, Inflammation Research.

Insulin and Insulin‐like Growth Factor 1 Stimulate Proliferation of Metastatic Variants of Colon Carcinoma 26

T. Tsuruo, T. Yamori, Mitsuo Koenuma, 1989, Japanese journal of cancer research : Gann.

Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.

K. Ogawa, T. Umehara, S. Yokoyama, 2016, Journal of medicinal chemistry.

SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells*

J. Inazawa, K. Miyazono, M. Matsuoka, 2009, Journal of Biological Chemistry.

Growth stimulating activity of lung extract on lung-colonizing colon 26 clones and its partial characterization

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1988, Clinical & Experimental Metastasis.

Sesquiterpenoids and flavonoids from the aerial parts of Tithonia diversifolia and their cytotoxic activity.

T. Yamori, R. Kobayashi, Y. Mimaki, 2007, Chemical & pharmaceutical bulletin.

Stromal Cells Positively and Negatively Modulate the Growth of Cancer Cells: Stimulation via the PGE2-TNFα-IL-6 Pathway and Inhibition via Secreted GAPDH-E-Cadherin Interaction

A. Nomoto, H. Inoue, M. Kawada, 2015, PloS one.

Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells.

S. Dan, T. Yamori, 2001, Biochemical and biophysical research communications.

Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.

Dexin Kong, T. Yamori, M. Okamura, 2009, European journal of cancer.

Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis

S. Nada, M. Okada, T. Yamori, 2004, Oncogene.

In Vitro Antitumor Activity of Stellettin B, a Triterpene from Marine Sponge Jaspis stellifera, on Human Glioblastoma Cancer SF295 Cells

S. Dan, Dexin Kong, Qianxiang Zhou, 2014, Marine drugs.

Ridaifen-SB8, a novel tamoxifen derivative, induces apoptosis via reactive oxygen species-dependent signaling pathway.

S. Dan, T. Yamori, Wenzhi Guo, 2013, Biochemical pharmacology.

Identification of a molecular target of kurahyne, an apoptosis-inducing lipopeptide from marine cyanobacterial assemblages.

S. Dan, T. Yamori, A. Iwasaki, 2015, Bioorganic & medicinal chemistry letters.

Insulin-like Growth Factor I Rapidly Induces Tyrosine Phosphorylation of a Mr 150 , 000 and a Mr 160 , 000 Protein in Highly Metastatic Mouse Colon Carcinoma 26 NL-17 Cells 1

T. Tsuruo, T. Yamori, S. Iwashita, 2006 .

Expression of Sulfomucins in Normal Mucosae, Colorectal Adenocarcinomas and Metastases

T. Irimura, T. Yamori, S. Yonezawa, 1995, Japanese journal of cancer research : Gann.

Inhibitory effects of tumor invasion-inhibiting factor 2 and its conjugate on disseminating tumor cells.

T. Tsuruo, A. Raz, T. Yamori, 1994, Cancer research.

Insulin-like growth factor I rapidly induces tyrosine phosphorylation of a Mr 150,000 and a Mr 160,000 protein in highly metastatic mouse colon carcinoma 26 NL-17 cells.

T. Tsuruo, T. Yamori, S. Iwashita, 1991, Cancer research.

Spontaneous metastasis of highly metastatic variants of mouse tumors and the effect of drugs on the metastasis.

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1984, Gan.

Metastasis after intravenous inoculation of highly metastatic variants of mouse tumors and the effects of several antitumor drugs on the tumors.

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1984, Gan.

Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases.

D. Ota, T. Irimura, K. Cleary, 1989, Cancer research.

Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers.

J. Gustafsson, Y. Ishikawa, H. Iwase, 2001, Biochemical and Biophysical Research Communications - BBRC.

Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung Cancers

J. Gustafsson, Y. Ishikawa, H. Iwase, 2001 .

Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression

T. Tsuruo, R. Kannagi, T. Yamori, 2002, International journal of cancer.

M‐COPA, a novel Golgi system disruptor, suppresses apoptosis induced by Shiga toxin

S. Dan, M. Naito, T. Yamori, 2016, Genes to cells : devoted to molecular & cellular mechanisms.

Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis.

Y. Nakamura, H. Nakagawa, Y. Miyoshi, 2000, Genes, chromosomes & cancer.

Antibacterial and antiproliferative activity of cationic fullerene derivatives.

T. Yamori, Daiki Nishikawa, T. Mashino, 2003, Bioorganic & medicinal chemistry letters.

Expression of insulin receptor substrate-1 in hepatocytes: an investigation using monoclonal antibodies.

T. Tsuruo, M. Kasuga, T. Tanaka, 1994, Cancer letters.

Large Molecule Therapeutics Ef fi cacy of RG 7787 , a Next-Generation Mesothelin-Targeted Immunotoxin , against Triple-Negative Breast and Gastric Cancers

I. Pastan, T. Yamori, K. Bosslet, 2014 .

Efficacy of RG7787, a Next-Generation Mesothelin-Targeted Immunotoxin, against Triple-Negative Breast and Gastric Cancers

I. Pastan, T. Yamori, K. Bosslet, 2014, Molecular Cancer Therapeutics.

Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics

T. Terasaki, T. Yamori, S. Ohtsuki, 2013, Molecular Pharmacology.

Identification of interleukin-6 as a factor that induces neurite outgrowth by PC12 cells primed with NGF.

A. Komi, A. Iwamatsu, T. Yamori, 1996, Journal of Biochemistry (Tokyo).

A new evaluation method for quantifying PI3K activity by HTRF assay.

A. Tomida, S. Dan, Dexin Kong, 2008, Biochemical and biophysical research communications.

Resistance of Human Cancer Cell Lines Activating Transcription Factor 4 Increases the Cisplatin

K. Yasumoto, H. Izumi, K. Kohno, 2003 .

Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines.

K. Yasumoto, H. Izumi, K. Kohno, 2003, Cancer research.

ZSTK474, a specific phosphatidylinositol 3-kinase inhibitor, induces G1 arrest of the cell cycle in vivo.

A. Miyawaki, Asako Sakaue-Sawano, Y. Inoue, 2012, European journal of cancer.

Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest.

S. Dan, T. Yamori, M. Okamura, 2009, Biochemical and biophysical research communications.

Potentiation of bleomycin in Jurkat cells by fungal pycnidione.

T. Yamori, T. Fukuda, H. Tomoda, 2012, Biological & pharmaceutical bulletin.

Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid*

Y. Kishi, T. Yamori, H. Arai, 2006, Journal of Biological Chemistry.

Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition.

Ryohei Katayama, Naoya Fujita, Jie Qi, 2013, Cancer research.

New Dolabellane-Type Diterpenoids from the Okinawan Soft Coral of the Genus Clavularia

K. Iguchi, T. Yamori, Hisako Sawai, 2002 .

Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.

S. Dan, T. Yamori, M. Kaiser, 2013, European journal of medicinal chemistry.

Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential.

T. Tsuruo, Y. Sugimoto, T. Yamori, 1987, Cancer research.

Abdominal Infection Suppresses the Number and Activity of Intrahepatic Natural Killer Cells and Promotes Tumor Growth in a Murine Liver Metastasis Model

Kazumichi Yoshida, N. Shinomiya, T. Yamori, 2016, Annals of Surgical Oncology.

Enhanced cytocidal action of methotrexate by conjugation to concanavalin A

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1980, International journal of cancer.

Total Synthesis of the Depsipeptide FR901375 and Preliminary Evaluation of Its Biological Activity

Minoru Yoshida, T. Yamori, A. Ito, 2016 .

Production of monoclonal antibodies specific to the carboxyl terminal region of the 85 kDa subunit of phosphatidylinositol 3‐kinase: Use of the antibodies in recognition of mutant p85

M. Matsuda, K. Onodera, T. Yamori, 1995, Immunology and cell biology.

Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase.

Dexin Kong, T. Yamori, S. Yaguchi, 2009, Biological & pharmaceutical bulletin.

Isolation of a novel gene on 8p21.3–22 whose expression is reduced significantly in human colorectal cancers with liver metastasis

Yusuke Nakamura, H. Nakagawa, Y. Miyoshi, 2000 .

The relationship of collagenolytic activity to stage of human colorectal carcinoma

D. Ota, T. Irimura, K. Cleary, 1987, International journal of cancer.

Smac Peptide : Therapeutic Effect of a Novel Polyarginine-conjugated CellsApoptosis Protein in Non-Small Cell Lung Cancer H 460 Predominant Suppression of Apoptosome by Inhibitor of Updated

T. Tsuruo, Shigeo Sato, T. Mashima, 2003 .

Convergent synthesis of stereoisomers of THF ring moiety of acetogenin thiophene analogue and their antiproliferative activities against human cancer cell lines

S. Dan, T. Yamori, M. Yamashita, 2017 .

A Potential Role of Adhesion Molecules on Lung Metastasis Enhanced by Local Inflammation

H. Ueno, N. Shinomiya, T. Yamori, 2020, AntiCancer Research.

Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting

Yu Matsumoto, Kazunori Kataoka, Shourong Wu, 2011, Science Translational Medicine.

Reforms of regulatory pathways for approval of new antineoplastic drugs in Japan from 2004 to 2019 and accompanying changes in pivotal clinical trial designs

T. Yamori, Takehiro Hirai, Masaaki Matsuura, 2021, Investigational New Drugs.

Development of lymphosarcoma lines with high metastatic ability to lymph nodes and visceral organs in BALB/c mice

T. Tsuruo, T. Ishikawa, T. Yamori, 1988, Clinical & Experimental Metastasis.

Inhibition of lung colonization of mouse colon 26 adenocarcinoma by recombinant mouse interferon β through a modification of platelet function

T. Tsuruo, Y. Sugimoto, T. Yamori, 1990, Clinical & Experimental Metastasis.

Inhibition of spontaneous and experimental tumor metastasis by the calcium antagonist verapamil

T. Tsuruo, T. Yamori, S. Tsukagoshi, 2004, Cancer Chemotherapy and Pharmacology.

Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26.

T. Tsuruo, M. Nakajima, T. Yamori, 1995, Cancer research.

Establishment of a Hepatocyte Cell Line Producing Growth‐promoting Factors for Liver‐colonizing Tumor Cells

T. Tsuruo, N. Nemoto, A. Komi, 1996, Japanese journal of cancer research : Gann.

Urukthapelstatin A, a Novel Cytotoxic Substance from Marine-derived Mechercharimyces asporophorigenens YM11-542

K. Shin‐ya, H. Kasai, T. Yamori, 2007, The Journal of Antibiotics.

Antitumor effect of cotylenin A plus interferon-alpha: possible therapeutic agents against ovary carcinoma.

Y. Honma, T. Yamori, N. Kato, 2005, Gynecologic oncology.

Synthesis and biological relationships of 3',6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents.

S. Kuo, Li‐Jiau Huang, T. Yamori, 2005, Bioorganic & medicinal chemistry.

Synthesis of hybrid acetogenins, alpha,beta-unsaturated-gamma-lactone-free nitrogen-containing heterocyclic analogues, and their cytotoxicity against human cancer cell lines.

T. Yamori, Tetsuaki Tanaka, N. Kojima, 2008, Bioorganic & medicinal chemistry letters.

A novel thiophene‐3‐carboxamide analog of annonaceous acetogenin exhibits antitumor activity via inhibition of mitochondrial complex I

S. Dan, T. Yamori, N. Kojima, 2016, Pharmacology research & perspectives.

Synthesis of dansyl-labeled probe of thiophene analogue of annonaceous acetogenins for visualization of cell distribution and growth inhibitory activity toward human cancer cell lines.

S. Dan, T. Yamori, M. Yamashita, 2015, Bioorganic & medicinal chemistry.

Thiophene-3-carboxamide analogue of annonaceous acetogenins as antitumor drug lead.

S. Dan, T. Yamori, M. Yamashita, 2014, European journal of medicinal chemistry.

Structure-activity relationships of hybrid annonaceous acetogenins: powerful growth inhibitory effects of their connecting groups between heterocycle and hydrophobic carbon chain bearing THF ring on human cancer cell lines.

S. Dan, T. Yamori, M. Yamashita, 2013, European journal of medicinal chemistry.

Design and synthesis of C35-fluorinated solamins and their growth inhibitory activities against human cancer cell lines.

T. Yamori, Tetsuaki Tanaka, N. Kojima, 2011, Bioorganic & medicinal chemistry letters.

Convergent synthesis of fluorescence-labeled probes of Annonaceous acetogenins and visualization of their cell distribution.

T. Yamori, D. Urabe, Y. Fujimoto, 2010, Bioorganic & medicinal chemistry.

Synthesis of C4-fluorinated solamins and their growth inhibitory activity against human cancer cell lines.

T. Yamori, Tetsuaki Tanaka, N. Kojima, 2008, Bioorganic & medicinal chemistry letters.

Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.

S. Hirono, T. Yamori, H. Gouda, 2006, Journal of the National Cancer Institute.

Total synthesis of murisolins and evaluation of tumor-growth inhibitory activity.

T. Yamori, D. Urabe, Tetsuaki Tanaka, 2005, Chemistry.

Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel.

T. Tsuruo, Shigeo Sato, S. Sato, 1999, Cancer research.

Production of biologically active taxoids by a callus culture of Taxus cuspidata.

A. Tomida, T. Tsuruo, T. Yamori, 2004, Journal of natural products.

Mami Murakami Subcellular Targeting Improving Drug Potency and Efficacy by Nanocarrier-Mediated

Y. Matsumoto, M. Kano, N. Nishiyama, 2010 .

Yaku'amides A and B, cytotoxic linear peptides rich in dehydroamino acids from the marine sponge Ceratopsion sp.

R. Ueoka, T. Yamori, S. Okada, 2010, Journal of the American Chemical Society.

Correlation between Cytotoxic Activities and Reduction Potentials of Heterocyclic Quinones

T. Yamori, J. Koyama, I. Morita, 2010, Molecules.

YM-216391, a Novel Cytotoxic Cyclic Peptide from Streptomyces nobilis

T. Yamori, A. Tanaka, K. Nagai, 2005, The Journal of Antibiotics.

Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity

Hye-Sook Kim, Y. Wataya, T. Yamori, 1999 .

Array-based structure and gene expression relationship study of antitumor sulfonamides including N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide and N-(3-chloro-7-indolyl)-1,4-benzenedisulfonamide.

T. Owa, T. Nagasu, T. Yamori, 2002, Journal of medicinal chemistry.

Synthesis and in vitro cancer cell growth inhibition evaluation of 11-amino-modified 5-Me-indolo[2,3-b]quinolines and their COMPARE analyses

S. Dan, M. Seno, T. Yamori, 2016, Medicinal Chemistry Research.

Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.

T. Yamori, M. Chikuma, Toshihiro Suzuki, 2013, Metallomics : integrated biometal science.

Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agent.

Chi-Hung Huang, Shih-Ming Huang, S. Kuo, 2010, Journal of medicinal chemistry.

Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole

K. Shin‐ya, I. Nakano, Yue Ma, 2017, Scientific Reports.

Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-δ7-prostaglandin A1 methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826)

S. Fukushima, H. Sasaki, K. Furuta, 2001, Anti-cancer drugs.

Effect on tumor cells of blocking survival response to glucose deprivation.

Takashi Tsuruo, Hae-Ryong Park, Kazuo Shin-ya, 2004, Journal of the National Cancer Institute.

Discovery of ortho-Carborane-Conjugated Triazines as Selective Topoisomerase I/II Inhibitors

T. Yamori, S. Kang, Atsushi Shoji, 2011 .

Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamides.

H. Sugiyama, N. Fukuda, Z. Tao, 2003, Chemistry & biology.

Synthesis and Biological Evaluation of Boronic Acid Containing cis‐Stilbenes as Apoptotic Tubulin Polymerization Inhibitors

T. Yamori, K. Maruyama, R. Suzuki, 2006, ChemMedChem.

Anticancer and some biological activities of thiazinotrienomycin B.

T. Yamori, S. Sato, T. Takeuchi, 2000, The Journal of antibiotics.

Pyrrocidine A, a metabolite of endophytic fungi, has a potent apoptosis-inducing activity against HL60 cells through caspase activation via the Michael addition

S. Dan, T. Yamori, K. Kimura, 2015, The Journal of Antibiotics.

Leptosins isolated from marine fungus Leptoshaeria species inhibit DNA topoisomerases I and/or II and induce apoptosis by inactivation of Akt/protein kinase B

Miyako Yanagihara, T. Andoh, T. Yamori, 2005, Cancer science.

Synthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity

T. Yamori, S. Kizaka-Kondoh, Shinichi Sato, 2012 .

Novel antitumour metabolites produced by a fungal strain from a sea hare

T. Tsuruo, T. Yamori, E. Matsumura, 1997 .

Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions.

H. Esumi, M. Kawada, T. Yamori, 2010, Biochemical and biophysical research communications.

Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines

J. Kanno, T. Yamori, Tomoki Nakamura, 2007, Molecular Pharmacology.

Application of in vivo ESR/spin-probe technique to monitor tumor in vivo in mouse footpad.

T. Tsuruo, M. Tsuneyoshi, H. Utsumi, 2007, Antioxidants & redox signaling.

Isolation and structures of biselyngbyasides B, C, and D from the marine cyanobacterium Lyngbya sp., and the biological activities of biselyngbyasides

Toshiyasu Inuzuka, T. Yamori, K. Suenaga, 2012 .

In vitro cytotoxicity of the protoberberine-type alkaloids.

T. Yamori, K. Iwasa, M Moriyasu, 2001, Journal of natural products.

Inhibition of DNA topoisomerases II and/or I by pyrazolo[1,5-a]indole derivatives and their growth inhibitory activities.

T. Andoh, T. Yamori, K. Umemura, 2002, Molecular pharmacology.

The polar neutral and basic taxoids isolated from needles and twigs of Taxus cuspidata and their biological activity

A. Tomida, T. Tsuruo, T. Yamori, 2008, Journal of Wood Science.

Triterpene saponins from the roots of Clematis chinensis.

T. Yamori, Takao Yamori, Akihito Yokosuka, 2004, Journal of natural products.

Suppressive effects of the bacterial immunostimulant OK-432 on the incidence of spontaneous thymic lymphoma in AKR mice.

T. Yamori, H. Akazawa, T. Watanabe, 1989, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Inhibitory Activity of Flavonoids against Class I Phosphatidylinositol 3-Kinase Isoforms

Dexin Kong, Meihua Jin, T. Yamori, 2011, Molecules.

Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice.

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1981, The Journal of antibiotics.

Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics

T. Yamori, Takao Yamori, 2003, Cancer Chemotherapy and Pharmacology.

New biologically active marine sesquiterpenoid and steroid from the okinawan sponge of the genus Axinyssa.

K. Iguchi, T. Yamori, M. Iwashima, 2002, Chemical & pharmaceutical bulletin.

Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells.

T. Tsuruo, Shigeo Sato, T. Mashima, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect.

T. Tsuruo, T. Yamori, S. Natori, 2000, Anticancer research.

Cytotoxic dimeric sesquiterpenoids from Curcuma parviflora : isolation of three new parviflorenes and absolute stereochemistry of parviflorenes A, B,D, F, and G

T. Yamori, T. Koyano, M. Ishibashi, 2005 .

Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro.

T. Yamori, K. Ryoyama, T. Nomura, 2005, Cancer detection and prevention.

Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis

T. Tsuruo, T. Yamori, H. Iida, 2004, Clinical & Experimental Metastasis.

Glycoconjugates and tumor metastasis.

D. Ota, T. Irimura, G. Nicolson, 1988, Advances in experimental medicine and biology.

Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays

Noriyuki Nakatsu, Tomoki Nakamura, S. Dan, 2005, Molecular Cancer Therapeutics.

Isolation and characterization of highly and rarely metastatic clones from murine colon adenocarcinoma 26.

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1984, Invasion & metastasis.

Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma.

T Irimura, D. Ota, T. Irimura, 1989, Cancer research.

Alkyl isothiocyanates suppress epidermal growth factor receptor kinase activity but augment tyrosine kinase activity.

Y. Uehara, T. Yamori, K. Ryoyama, 2009, Cancer epidemiology.

Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases.

T Irimura, D. Ota, T. Irimura, 1987, Cancer research.

Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues.

D. Ota, T. Irimura, K. Cleary, 1988, Cancer research.

Ectopic expression of mucins in colorectal cancer metastasis.

D. Ota, T. Irimura, M. Frazier, 1991, Seminars in cancer biology.

Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin

T. Sasaki, T. Yamori, T. Endo, 2002, British Journal of Cancer.

Inhibition of DNA topoisomerases I and II, and growth inhibition of human cancer cell lines by a marine microalgal polysaccharide.

T. Andoh, T. Yamori, K. Yanase, 2003, Biochemical pharmacology.

Isolation of peridinin-related norcarotenoids with cell growth-inhibitory activity from the cultured dinoflagellate of Symbiodinium sp., a symbiont of the Okinawan soft coral Clavularia viridis, and analysis of fatty acids of the dinoflagellate.

K. Iguchi, T. Yamori, M. Tsuzuki, 2003, Chemical & pharmaceutical bulletin.

Isolation of Peridinin‐Related Norcarotenoids with Cell Growth‐Inhibitory Activity from the Cultured Dinoflagellate of Symbiodinium sp., a Symbiont of the Okinawa Soft Coral Clavularia viridis, and Analysis of Fatty Acids of the Dinoflagellate.

K. Iguchi, T. Yamori, M. Tsuzuki, 2003 .

Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities.

T. Yamori, K. Okamoto, Y. Mizui, 2004, The Journal of antibiotics.

Leptosins M—N1, Cytotoxic Metabolites from a Leptosphaeria Species Separated from a Marine Alga. Structure Determination and Biological Activities.

T. Andoh, Y. Uehara, T. Yamori, 2002 .

Telomestatin Impairs Glioma Stem Cell Survival and Growth through the Disruption of Telomeric G-Quadruplex and Inhibition of the Proto-oncogene, c-Myb

K. Shin‐ya, Kaushal Joshi, I. Nakano, 2012, Clinical Cancer Research.

Absolute quantification of four isoforms of the class I phosphoinositide-3-kinase catalytic subunit by real-time RT-PCR.

M. Unno, S. Dan, T. Yamori, 2007, Biological & pharmaceutical bulletin.

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

K. Semba, S. Dan, T. Yamori, 2018, Oncotarget.

Spiromarienonols A and B: Two New 7(8→9)abeo‐Lanostane‐Type Triterpene Lactones from the Stem Bark of Abies mariesii.

T. Yamori, S. Wada, R. Tanaka, 2004 .

Spiromarienonols A and B: Two New 7(8¿9)abeo-Lanostane-Type Triterpene Lactones from the Stem Bark of Abies mariesii

T. Yamori, S. Wada, R. Tanaka, 2004 .

Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors

A. Nomoto, S. Dan, T. Yamori, 2014, Cancer science.

Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluations.

Y. Ishikawa, S. Dan, T. Yamori, 2010, Cancer research.

Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39.

S. Dan, Dexin Kong, T. Yamori, 2010, European journal of cancer.

ZSTK474 is an ATP‐competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms

Dexin Kong, T. Yamori, 2007, Cancer science.

Identification of JTP‐70902, a p15INK4b‐inductive compound, as a novel MEK1/2 inhibitor

Makoto Koyama, Takayuki Yamaguchi, Kazuhide Hayakawa, 2007, Cancer science.

Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors

Ryohei Katayama, S. Dan, N. Fujita, 2017, Oncotarget.

A novel method for analyzing phosphoproteins using SELDI‐TOF MS in combination with a series of recombinant proteins

T. Yamori, T. Akashi, Tetsuyuki Akashi, 2007, Proteomics.

Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer.

T. Yamori, Y. Nishimura, T. Akashi, 2007, Biochemical and biophysical research communications.

Family-wide Analysis of the Inhibition of Arf Guanine Nucleotide Exchange Factors with Small Molecules: Evidence of Unique Inhibitory Profiles.

J. Cherfils, M. Zeghouf, S. Dan, 2017, Biochemistry.

Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation

A. Tomida, S. Saito, S. Dan, 2015, Cancer science.

A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells

T. Noda, T. Yamori, M. Inoue, 2014, Oncogene.

ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system

T. Yamori, De-Xin Kong, 2010, Acta Pharmacologica Sinica.

FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis.

T. Tsuruo, H. Seimiya, T. Yamori, 1999, Cancer research.

A Potent Telomerase Inhibitor Identified by Exploiting the Disease-oriented Screening Program with COMPARE Analysis 1

T. Tsuruo, H. Seimiya, T. Yamori, 1999 .

Synthesis of functional proteins by mixing peptide motifs.

T. Noda, T. Yamori, K. Shiba, 2004, Chemistry & biology.

A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue.

F. Akiyama, Y. Hirai, S. Dan, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.

T. Tsuruo, T. Kawabe, M. Omata, 2005, Cancer research.

Phosphatidylinositol 3‐kinase inhibitors: promising drug candidates for cancer therapy

Dexin Kong, T. Yamori, 2008, Cancer science.

Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

Takashi Tsuruo, Hiroshi Sakamoto, T. Tsuruo, 2003, Cancer research.

Comparative profiling of the gene expression for estrogen responsiveness in cultured human cell lines.

T. Yamori, R. Kiyama, S. Hayashi, 2007, Toxicology in vitro : an international journal published in association with BIBRA.

p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.

Takashi Tsuruo, Hiroshi Tomoda, Jun-ichi Hamada, 2005, Journal of the National Cancer Institute.

p 53-Defective Tumors With a Functional Apoptosome-Mediated Pathway : A New Therapeutic Target

T. Tsuruo, Shigeo Sato, Y. Ishikawa, 2005 .

Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI 3 K superfamily and human cancer cell line panel

S. Dan, Dexin Kong, T. Yamori, 2010 .

In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA

S. Dan, Dexin Kong, T. Yamori, 2014, Investigational New Drugs.

STUDIES In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK 3 CA

S. Dan, Dexin Kong, T. Yamori, 2014 .

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

G. Mills, Y. Kishi, N. Dohmae, 2002, The Journal of cell biology.

Overview of molecular target-based drugs

T. Yamori, 2006 .

Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity.

Minoru Yoshida, T. Yamori, A. Ito, 2014, European journal of medicinal chemistry.

Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities.

Minoru Yoshida, T. Yamori, A. Ito, 2013, European journal of medicinal chemistry.

Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform.

Y. Kato, T. Yamori, Y. Nishimura, 2003, Biochemical and biophysical research communications.

Leptosins M–N1, cytotoxic metabolites from a Leptosphaeria species separated from a marine alga. Structure determination and biological activities

T. Andoh, Y. Uehara, T. Yamori, 2002 .

Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells

H. Seimiya, Y. Sugimoto, T. Yamori, 2018, Scientific Reports.

Increased content of chondroitin sulfate proteoglycan in human colorectal carcinoma metastases compared with the primary tumor as determined by an anti‐chondroitin‐sulfate monoclonal antibody

D. Ota, T. Irimura, K. Cleary, 1988, Journal of cellular biochemistry.

Establishment of phosphatidylinositol 3‐kinase inhibitor‐resistant cancer cell lines and therapeutic strategies for overcoming the resistance

T. Irimura, S. Dan, T. Yamori, 2012, Cancer science.

M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers.

S. Dan, T. Yamori, K. Yoshimatsu, 2016, Cancer research.

Cancer Therapy : Preclinical Transient PI 3 K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Wei Wang, S. Sone, S. Yano, 2011 .

Transient PI3K Inhibition Induces Apoptosis and Overcomes HGF-Mediated Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer

Wei Wang, S. Sone, S. Yano, 2011, Clinical Cancer Research.

Antiproliferative and Antiangiogenic Activities of Smenospongine, a Marine Sponge Sesquiterpene Aminoquinone

Dexin Kong, Motomasa Kobayashi, T. Yamori, 2011, Marine drugs.

Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor

A. Tomida, S. Dan, H. Seimiya, 2021, Cancer science.

Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats

Y. Takasaki, T. Yamori, N. Tamura, 2012, Inflammation Research.

Primary resistance induced in mice by Lactobacillus casei following infection with herpes simplex virus.

T. Yamori, T. Watanabe, 1989, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice

Y. Takasaki, T. Yamori, N. Tamura, 2010, Arthritis research & therapy.

New bisindole alkaloids isolated from Myxomycetes Arcyria cinerea and Lycogala epidendrum.

T. Yamori, M. Hayashi, M. Ishibashi, 2005, Chemical & pharmaceutical bulletin.

Development of cDNA microarray for expression profiling of estrogen-responsive genes.

T. Yamori, R. Kiyama, Y. Omoto, 2002, Journal of molecular endocrinology.

The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

J. Kanno, J. Toutain, J. Robert, 2009, British Journal of Cancer.

Screening with COMPARE analysis for telomerase inhibitors.

T. Tsuruo, T. Yamori, I. Naasani, 2002, Methods in molecular biology.

Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines

Yusuke Nakamura, S. Dan, T. Yamori, 2003, Cancer science.

An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.

Yusuke Nakamura, T. Tsunoda, O. Kitahara, 2002, Cancer research.

Development of a gene expression database and related analysis programs for evaluation of anticancer compounds

A. Tomida, S. Saito, S. Dan, 2013, Cancer science.

Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.

T. Tsuruo, Shigeo Sato, M. Yoshida, 2001, Cancer research.

Cytochrome P450 1B1 Gene Polymorphisms as Predictors of Anticancer Drug Activity: Studies with In vitro Models

J. Robert, T. Yamori, A. Laroche-Clary, 2010, Molecular Cancer Therapeutics.

Preclinical Development Cytochrome P 450 1 B 1 Gene Polymorphisms as Predictors of Anticancer Drug Activity : Studies with In vitro Models

J. Robert, T. Yamori, A. Laroche-Clary, 2010 .

Development of new topoisomerase II-targeting compounds as candidate anticancer drugs

T. Andoh, T. Yamori, K. Umemura, 2003 .

Disruption of Tacc3 function leads to in vivo tumor regression

T. Noda, T. Saga, H. Shioya, 2012, Oncogene.

TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling

T. Noda, K. Miyazono, C. Heldin, 2018, Cell Discovery.

Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1*

Masahiko Watanabe, J. Chun, Y. Kishi, 2004, Journal of Biological Chemistry.

Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).

K. Miyazono, K. Miyazawa, T. Imamura, 2004, Oncogene.

Glaziovianin A, a new isoflavone, from the leaves of Ateleia glazioviana and its cytotoxic activity against human cancer cells.

T. Yamori, T. Usui, H. Osada, 2007, Bioorganic & medicinal chemistry letters.

Triterpene glycosides from Curculigo orchioides and their cytotoxic activity.

Koji Sato, T. Yamori, Takao Yamori, 2010, Journal of natural products.

The G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) facilitates tumor development by serving as an extracellular pH sensor

H. Aburatani, M. Fukayama, Takao Shimizu, 2010, Proceedings of the National Academy of Sciences.

Nucleotide sequence variation is frequent in the mitochondrial DNA displacement loop region of individual human tumor cells.

K. Koike, Y. Kato, T. Yamori, 2005, Molecular cancer research : MCR.

Search for novel anti-tumor agents from ridaifens using JFCR39, a panel of human cancer cell lines.

S. Dan, T. Yamori, Wenzhi Guo, 2013, Biological & pharmaceutical bulletin.

Total synthesis of AMF-26, an antitumor agent for inhibition of the Golgi system, targeting ADP-ribosylation factor 1.

S. Dan, T. Yamori, Isamu Shiina, 2013, Journal of medicinal chemistry.

Cytotoxic Dimeric Sesquiterpenoids from Curcuma parviflora: Isolation of Three New Parviflorenes and Absolute Stereochemistry of Parviflorenes A, B, D, F, and G.

T. Yamori, T. Koyano, M. Ishibashi, 2005 .

articleInhibitory effects of ZSTK 474 , a novel phosphoinositide 3-kinase inhibitor , on osteoclasts and collagen-induced arthritis in mice

Y. Takasaki, T. Yamori, N. Tamura, 2015 .

JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.

Dexin Kong, T. Yamori, 2012, Bioorganic & medicinal chemistry.

Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents.

M. Ikekita, Y. Nagahara, T. Yamori, 2008, Biochemical pharmacology.

Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics

F. Akiyama, R. Horii, S. Dan, 2015, International Journal of Clinical Oncology.

Up‐regulation of p27Kip1 Correlates Inversely with Anchorage‐independent Growth of Human Cancer Cell Lines

T. Tsuruo, M. Kawada, S. Mizuno, 1998, Japanese journal of cancer research : Gann.

Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.

A. Tomida, T. Tsuruo, T. Yamori, 2007, Bioorganic & medicinal chemistry letters.

Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells.

T. Tsuruo, S. Sato, T. Yamori, 1999, Cancer detection and prevention.

Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.

Y. Ishikawa, T. Morikawa, T. Yamori, 2010, Lung cancer.

Galtonioside A, a novel cytotoxic cholestane glycoside from Galtonia candicans

T. Tsuruo, T. Yamori, Y. Mimaki, 2000 .

Ridaifen G, tamoxifen analog, is a potent anticancer drug working through a combinatorial association with multiple cellular factors.

K. Morohashi, F. Sugawara, S. Dan, 2015, Bioorganic & medicinal chemistry.

AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy

Shuichi Hirono, Noriyuki Yamaotsu, Hiroshi Iijima, 2011, The Journal of Biological Chemistry.

Effectiveness of combined treatment using X‐rays and a phosphoinositide 3‐kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo

R. Okayasu, S. Dan, T. Yamori, 2011, Cancer science.

Marine diterpenoids with a briarane skeleton from the Okinawan soft coral Pachyclavularia violacea.

K. Iguchi, T. Yamori, Hisanaka Ito, 2007, Chemical & pharmaceutical bulletin.

Anti‐tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts

Shigeo Sato, T. Yamori, T. Kadota, 1997, Japanese journal of cancer research : Gann.

Structural Revision of Sulfated Polysaccharide B-1 Isolated from a Marine Pseudomonas Species and Its Cytotoxic Activity Against Human Cancer Cell Lines

M. Matsuda, T. Yamori, K. Okutani, 2003, Marine Biotechnology.

Discovery of phosphatidylinositol 3-kinase inhibitory compounds from the Screening Committee of Anticancer Drugs (SCADS) library.

Dexin Kong, T. Yamori, K. Yamazaki, 2010, Biological & pharmaceutical bulletin.

Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell lines.

S. Dan, T. Yamori, Tomoki Nakamura, 2009, Biological & pharmaceutical bulletin.

Development of a system to predict molecular targets of novel compounds: its application to anticancer drug discovery (Symposium in the 26th annual meeting of Medical and Pharmaceutical Society for Wakan-Yaku: Molecular science and Kampo medicine)

T. Yamori, 2010 .

Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107. Part 3. In vitro and in vivo Antitumor Activities.

T. Yamori, K. Okamoto, Y. Mizui, 2004 .

Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice

T. Tsuruo, T. Ashizawa, K. Gomi, 1994, Anti-cancer drugs.

Anticancer activities of orally administered menogaril against human stomach and breast cancers implanted in nude mice.

T. Tsuruo, Y. Ueyama, T. Yamori, 1992, Anticancer Research.

Enantioselective total synthesis of (+)-ottelione A, (-)-ottelione B, (+)-3-epi-ottelione A and preliminary evaluation of their antitumor activity.

H. Araki, M. Kohno, T. Yamori, 2007, Chemistry.

Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole

K. Shin‐ya, I. Nakano, H. Seimiya, 2017, Scientific Reports.

88 In silico and biological evaluation of correlation between efficacy of PI3K inhibitors with the activation status of signaling pathways in a panel of JFCR39 human cancer cell lines

Y. Ishikawa, S. Dan, T. Yamori, 2010 .

TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling

T. Noda, K. Miyazono, C. Heldin, 2018, Cell Discovery.

New cytotoxic oleanane-type triterpenoids from the cones of Liquidamber styraciflua.

T. Yamori, R. Tanaka, Yuko Fukuda, 2004, Journal of natural products.

Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226.

Jing-Gung Chung, S. Kuo, Li‐Jiau Huang, 2008, Biochemical pharmacology.

Motif‐programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria

T. Yamori, K. Shiba, Hirohide Saito, 2008, Cancer science.

Expression of carbohydrate-binding protein p33/41 in human tumor cell lines.

T. Tsuruo, T. Yamori, S. Sato, 1996, Journal of biochemistry.

Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.

T. Nakano, Takayoshi Suzuki, T. Yamori, 2009, Journal of medicinal chemistry.

Discovery of Inhibitors of Membrane Traffic from a Panel of Clinically Effective Anticancer Drugs.

T. Yamori, S. Sadahiro, Hiroko Kamata, 2019, Biological & pharmaceutical bulletin.

Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474

S. Dan, T. Yamori, Y. Nishimura, 2015, Cancer science.

Development of an immunohistochemical protein quantification system in conjunction with tissue microarray technology for identifying predictive biomarkers for phosphatidylinositol 3-kinase inhibitors.

T. Irimura, S. Dan, T. Yamori, 2012, Biological & pharmaceutical bulletin.

A Potential Mechanism of Tumor Progression during Systemic Infections Via the Hepatocyte Growth Factor (HGF)/c-Met Signaling Pathway

H. Ueno, N. Shinomiya, T. Yamori, 2020, Journal of clinical medicine.

Candicanoside A, a Novel Cytotoxic Rearranged Cholestane Glycoside from Galtonia candicans

T. Tsuruo, T. Yamori, Y. Mimaki, 2000 .

Glaziovianin A, a New Isoflavone, from the Leaves of Ateleia Glaziovianna and Its Cytotoxic Activity Against Human Cancer Cells.

T. Yamori, T. Usui, H. Osada, 2007 .

Antitumor efficacies of aclacinomycin A by oral administration.

T. Tsuruo, T. Yamori, S. Tsukagoshi, 1980, Journal of Pharmacobio-Dynamics.

Isolation of murine and human homologues of the fission-yeast dis3+ gene encoding a mitotic-control protein and its overexpression in cancer cells with progressive phenotype.

M Endo, Y. Nakamura, T. Tsuruo, 1997, Cancer research.